CA2140237A1 - Associations antivirales - Google Patents

Associations antivirales

Info

Publication number
CA2140237A1
CA2140237A1 CA002140237A CA2140237A CA2140237A1 CA 2140237 A1 CA2140237 A1 CA 2140237A1 CA 002140237 A CA002140237 A CA 002140237A CA 2140237 A CA2140237 A CA 2140237A CA 2140237 A1 CA2140237 A1 CA 2140237A1
Authority
CA
Canada
Prior art keywords
methyl
amino
ethyl
pyridinone
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002140237A
Other languages
English (en)
Inventor
Janet Mary Cameron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2140237A1 publication Critical patent/CA2140237A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002140237A 1992-07-16 1993-07-13 Associations antivirales Abandoned CA2140237A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929215176A GB9215176D0 (en) 1992-07-16 1992-07-16 Antiviral combinations
GB9215176.0 1992-07-16
PCT/EP1993/001846 WO1994002154A1 (fr) 1992-07-16 1993-07-13 Combinaisons antivirales

Publications (1)

Publication Number Publication Date
CA2140237A1 true CA2140237A1 (fr) 1994-02-03

Family

ID=10718842

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002140237A Abandoned CA2140237A1 (fr) 1992-07-16 1993-07-13 Associations antivirales

Country Status (6)

Country Link
EP (1) EP0650362A1 (fr)
JP (1) JPH07508997A (fr)
AU (1) AU4568893A (fr)
CA (1) CA2140237A1 (fr)
GB (1) GB9215176D0 (fr)
WO (1) WO1994002154A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763042A (en) * 1994-06-28 1998-06-09 Reichhold Chemicals, Inc. Reinforcing structural rebar and method of making the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
GB9215176D0 (en) 1992-08-26
WO1994002154A1 (fr) 1994-02-03
EP0650362A1 (fr) 1995-05-03
JPH07508997A (ja) 1995-10-05
AU4568893A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
US5627186A (en) Antiviral combinations
JP7366385B2 (ja) ヘルペスウイルス誘発疾患の処置のための方法および組成物
AU2002219497B2 (en) Use of an adenosine A3 receptor agonist for inhibition of viral replication
WO1997006804A1 (fr) Analogues de nucleosides 1,3-oxathiolane utilises dans le traitement de l'hepatite c
EA032868B1 (ru) Комбинация для лечения вич-инфекции
JPH0125A (ja) ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
US20240058347A1 (en) Dosages for hdac treatment with reduced side effects
JP2007520443A (ja) ピリミジンを含有するｎｎｒｔｉとｒｔインヒビターとの組み合わせ物
Balzarini et al. Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2', 3'-dideoxyinosine and 2', 3'-dideoxy-2, 6-diaminopurine riboside
EP3866778B1 (fr) Associations d'inhibiteurs de la réplication du virus de la grippe
TW202110452A (zh) 以組蛋白去乙醯酶抑制劑治療病毒相關癌症之方法
AU717025B2 (en) Composition and method for prevention and treatment of HIV-1 infection
US5612333A (en) Antiviral combinations
CA2140237A1 (fr) Associations antivirales
US10953011B2 (en) Methods of treating virally associated cancers with histone deacetylase inhibitors
Wutzler et al. Neuraminidase inhibitors in the treatment of influenza A and B–overview and case reports
CA2213621A1 (fr) Associations antivirales de bch-189 et de ritonavir
MX2015002684A (es) Combinacion de un inhibidor macrociclico de proteasas del vhc, un inhibidor del vhc no nucleosidico y ritonavir.
IT202100024668A1 (it) Composizioni e metodi per la terapia antivirale combinata
EP2431032A1 (fr) Agent anti-tumoral comprenant une association médicamenteuse de tégafur-giméracil-otéracil potassium et de l'oxaliplatine
ES2542017T5 (es) Combinaciones de una pirimidina que contiene NNRTI con inhibidores de la RT
KR20020073494A (ko) 약물내성 인체 면역결핍 바이러스 감염의 치료

Legal Events

Date Code Title Description
FZDE Dead